Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." "Big Asks": what can be changed to increase and speed progress on Alzheimer's disease research and treatment?
作者信息
Kukull Walter A
机构信息
National Alzheimer's Coordinating Center, Department of Epidemiology, University of Washington, Seattle, WA, USA.
出版信息
Alzheimers Dement. 2009 Mar;5(2):137-9. doi: 10.1016/j.jalz.2009.01.003.
Abstract
The focus of the 2008 Leon Thal Symposium was to identify issues and changes that might be facilitated by government agencies, industry, or the academic research community that might move the field forward: “Big Asks” for fundamental shifts in the way we deal with Alzheimer's disease (AD) research. These items are therefore aimed at macro rather than molecular changes, but their impact will carry to the molecular level of research to increase our understanding of etiology and treatment of AD and associated disorders.
摘要
相似文献
1
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." "Big Asks": what can be changed to increase and speed progress on Alzheimer's disease research and treatment?
Alzheimers Dement. 2009 Mar;5(2):137-9. doi: 10.1016/j.jalz.2009.01.003.
2
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
Alzheimers Dement. 2009 Mar;5(2):130-2. doi: 10.1016/j.jalz.2009.01.014.
3
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
Alzheimers Dement. 2009 Mar;5(2):140-2. doi: 10.1016/j.jalz.2009.01.004.
4
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
Alzheimers Dement. 2009 Mar;5(2):133-6. doi: 10.1016/j.jalz.2009.01.006.
5
Prevent Alzheimer's disease by 2020: a national strategic goal.
Alzheimers Dement. 2009 Mar;5(2):81-4. doi: 10.1016/j.jalz.2009.01.022.
6
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging.
Alzheimers Dement. 2009 Mar;5(2):105-7. doi: 10.1016/j.jalz.2009.01.010.
7
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
Alzheimers Dement. 2009 Mar;5(2):147-8. doi: 10.1016/j.jalz.2009.01.007.
8
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
Alzheimers Dement. 2009 Mar;5(2):149-53. doi: 10.1016/j.jalz.2009.01.012.
9
Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs".
Alzheimers Dement. 2010 Mar;6(2):156-7. doi: 10.1016/j.jalz.2010.01.006.
10
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.
Alzheimers Dement. 2009 Mar;5(2):172-9. doi: 10.1016/j.jalz.2009.01.023.
本文引用的文献
1
Mild cognitive impairment as a diagnostic entity.
J Intern Med. 2004 Sep;256(3):183-94. doi: 10.1111/j.1365-2796.2004.01388.x.
Zotero 插件